Thrombotic disease in critically ill children

Pediatric Critical Care Medicine

Volumn 12, Issue 1, 2011, Pages 80-89

  McCrory, Michael C ^a   Brady, Kenneth M ^a   Takemoto, Clifford ^a   Tobias, Joseph D ^b   Easley, R Blaine ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

arterial thromboembolism; pediatric; pulmonary embolus; thrombotic disease; venous thromboembolic disease

Indexed keywords

ANTITHROMBIN III; ANTIVITAMIN K; ARGATROBAN; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; D DIMER; DALTEPARIN; DANAPAROID; ENOXAPARIN; FIBRINOGEN; FIBRINOGEN DEGRADATION PRODUCT; HEPARIN; HIRULOG; HOMOCYSTEINE; LEPIRUDIN; LIPOPROTEIN A; LOW MOLECULAR WEIGHT HEPARIN; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; REVIPARIN; STREPTOKINASE; THROMBIN INHIBITOR; TINZAPARIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; WARFARIN;

AORTA THROMBOSIS; ARTERIAL THROMBOEMBOLISM; ARTERIOGRAPHY; ARTERY CATHETER; ARTICLE; BLEEDING; BLOOD CELL COUNT; BRAIN ISCHEMIA; CEREBRAL SINUS THROMBOSIS; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CRITICALLY ILL PATIENT; DEEP VEIN THROMBOSIS; DIAGNOSTIC TEST; DOPPLER ECHOCARDIOGRAPHY; DYSFIBRINOGENEMIA; EUGLOBULIN LYSIS TEST; FULMINATING PURPURA; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INTENSIVE CARE UNIT; INTRACARDIAC THROMBOSIS; INTRAVASCULAR CATHETER; ISCHEMIC HEART DISEASE; KIDNEY VEIN THROMBOSIS; LIMB ISCHEMIA; LOADING DRUG DOSE; LUNG EMBOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPOROSIS; PARTIAL THROMBOPLASTIN TIME; PHLEBOGRAPHY; PORTAL VEIN THROMBOSIS; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK FACTOR; THROMBOEMBOLISM; THROMBOSIS; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM;

EID: 78751671829     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3181ce7644     Document Type: Article

References (79)

1. Monagle P, Adams M, Mahoney M, et al: Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res 2000; 47:763-766
2. Emery JL: Pulmonary embolism in children. Arch Dis Child 1962; 37:591-595
3. Andrew M, David M, Adams M, et al: Venous thromboembolic complications (VTE) in children: First analyses of the Canadian Registry of VTE. Blood 1994; 83:1251-1257
4. Rohrer MJ, Cutler BS, MacDougall E, et al: A prospective study of the incidence of deep venous thrombosis in hospitalized children. J Vasc Surg 1996; 24:46-49; discussion, 50
5. Newall F, Wallace T, Crock C, et al: Venous thromboembolic disease: A single-centre case series study. J Paediatr Child Health 2006; 42:803-807
6. Stein PD, Hull RD, Kayali F, et al: Venous thromboembolism according to age: The impact of an aging population. Arch Intern Med 2004; 164:2260-2265
7. van Ommen CH, Heijboer H, Buller HR, et al: Venous thromboembolism in childhood: A prospective two-year registry in The Netherlands. J Pediatr 2001; 139:676-681
8. Stein PD, Kayali F, Olson RE: Incidence of venous thromboembolism in infants and children: Data from the National Hospital Discharge Survey. J Pediatr 2004; 145: 563-565
9. Buck JR, Connors RH, Coon WW, et al: Pulmonary embolism in children. J Pediatr Surg 1981; 16:385-391
10. deVeber G, Monagle P, Chan A, et al: Pro-thrombotic disorders in infants and children with cerebral thromboembolism. Arch Neu-rol 1998; 55: 1539-1543.
11. Parasuraman S, Goldhaber SZ: Venous thromboembolism in children. Circulation 2006; 113:e12-e16
12. Anton N, Massicotte MP: Venous thrombo-embolism in pediatrics. Semin Vasc Med 2001; 1:111-122
13. Andrew M, Brooker L, Mitchell L: Acquired antithrombin III deficiency secondary to as-paraginase therapy in childhood acute lym-phoblastic leukaemia. Blood Coagul Fibrino-lysis 1994; 5(Suppl 1):S24-S36; discussion, S59-S64
14. Monagle P, Newall F, Barnes C, et al: Arterial thromboembolic disease: A single-centre case series study. J Paediatr Child Health 2008; 44:28-32
15. Jordan LC: Stroke in childhood. Neurologist 2006; 12:94-102
16. Kirton A, deVeber G: Therapeutic approaches and advances in pediatric stroke. NeuroRx 2006; 3:133-142
17. Kannel WB, Skinner JJ Jr, Schwartz MJ, et al: Intermittent claudication. Incidence in the Framingham study. Circulation 1970; 41: 875-883
18. McMillian JA: Oski's Pediatrics. Fourth Edition. Philadelphia, Lippincott, Williams & Wilkins, 2006
19. Lichtman M: William's Hematology. Seventh Edition. New York, McGraw-Hill, 2006
20. Bertina RM, van der Linden IK, Engesser L, et al: Hereditary heparin cofactor II deficiency and the risk of development of thrombosis. Thromb Haemost 1987; 57:196-200
21. Sie P, Dupouy D, Pichon J, et al: Constitutional heparin co-factor II deficiency associated with recurrent thrombosis. Lancet 1985; 2:414-416
22. Hamamoto T, Yamamoto M, Nordfang O, et al: Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI). Evidence that the third Kunitz-type domain of TFPI is not essential for the inhibition of factor VIIa-tissue factor complexes on cell surfaces. J Biol Chem 1993; 268:8704-8710
23. Huang ZF, Higuchi D, Lasky N, et al: Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood 1997; 90:944-951
24. Andrew M: Developmental hemostasis: Relevance to thromboembolic complications in pediatric patients. Thromb Haemost 1995; 74:415-425
25. Bonnet F, Loriferne JF, Texier JP, et al: Evaluation of Doppler examination for diagnosis of catheter-related deep vein thrombosis. Intensive Care Med 1989; 15:238-240
26. Male C, Chait P, Andrew M, et al: Central venous line-related thrombosis in children: Association with central venous line location and insertion technique. Blood 2003; 101: 4273-4278
27. Monagle P, Chalmers E, Chan A, et al: Anti-thrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133(6 Suppl): 887S-968S
28. Male C, Julian JA, Massicotte P, et al: Significant association with location of central venous line placement and risk of venous thrombosis in children. Thromb Haemost 2005; 94:516-521
29. Beck C, Dubois J, Grignon A, et al: Incidence and risk factors of catheter-related deep vein thrombosis in a pediatric intensive care unit: A prospective study. J Pediatr 1998; 133: 237-241
30. David M, Andrew M: Venous thromboembolic complications in children. J Pediatr 1993; 123:337-346
31. McLean TW, Fisher CJ, Snively BM, et al: Central venous lines in children with lesser risk acute lymphoblastic leukemia: Optimal type and timing of placement. J Clin Oncol 2005; 23:3024-3029
32. Male C, Kuhle S, Mitchell L: Diagnosis of venous thromboembolism in children. Se-min Thromb Hemost 2003; 29:377-390
33. Andrew M, Marzinotto V, Pencharz P, et al: A cross-sectional study of catheter-related thrombosis in children receiving total paren-teral nutrition at home. J Pediatr 1995; 126: 358-363
34. Dubois J, Rypens F, Garel L, et al: Incidence of deep vein thrombosis related to peripherally inserted central catheters in children and adolescents. CMAJ 2007; 177:1185-1190
35. Kamala F, Boo NY, Cheah FC, et al: Randomized controlled trial of heparin for prevention of blockage of peripherally inserted central catheters in neonates. Acta Paediatr 2002; 91:1350-1356
36. Hermansen MC, Hermansen MG: Intravascu-lar catheter complications in the neonatal intensive care unit. Clin Perinatol 2005; 32: 141-156, vii
37. Graves PW, Davis AL, Maggi JC, et al: Femoral artery cannulation for monitoring in critically ill children: Prospective study. Crit Care Med 1990; 18:1363-1366
38. Kocis KC, Vermilion RP, Callow LB, et al: Complications of femoral artery cannulation for perioperative monitoring in children. J Thorac Cardiovasc Surg 1996; 112: 1399-1400
39. Andrew M, David M, deVeber G, et al: Arterial thromboembolic complications in paediatric patients. Thromb Haemost 1997; 78:715-725
40. Kulkarni S, Naidu R: Vascular ultrasound imaging to study immediate postcatheteriza-tion vascular complications in children. Catheter Cardiovasc Interv 2006; 68: 450-455
41. Kocis KC, Snider AR, Vermilion RP, et al: Two-dimensional and Doppler ultrasound evaluation of femoral arteries in infants after cardiac catheterization. Am J Cardiol 1995; 75:642-645
42. Monagle P: Thrombosis in pediatric cardiac patients. Semin Thromb Hemost 2003; 29: 547-555
43. Barrington KJ: Umbilical artery catheters in the newborn: Effects of catheter materials. Cochrane Database Syst Rev 2000(2): CD000949
44. Slogoff S, Keats AS, Arlund C: On the safety of radial artery cannulation. Anesthesiology 1983; 59:42-47
45. Sfeir R, Khoury S, Khoury G, et al: Ischaemia of the hand after radial artery monitoring. Cardiovasc Surg 1996; 4:456-458
46. Hack WW, Vos A, van der Lei J, et al: Incidence and duration of total occlusion of the radial artery in newborn infants after catheter removal. Eur J Pediatr 1990; 149: 275-277
47. de Neef M, Heijboer H, van Woensel JB, et al: The efficacy of heparinization in prolonging patency of arterial and central venous catheters in children: A randomized double-blind trial. Pediatr Hematol Oncol 2002; 19: 553-560
48. Cholette JM, Rubenstein JS, Alfieris GM, et al: Elevated risk of thrombosis in neonates undergoing initial palliative cardiac surgery. Ann Thorac Surg 2007; 84:1320-1325
49. Kohlhase B, Vielhaber H, Kehl HG, et al: Thromboembolism and resistance to activated protein C in children with underlying cardiac disease. J Pediatr 1996; 129:677-679 (Pubitemid 27498276)
50. Seipelt RG, Franke A, Vazquez-Jimenez JF, et al: Thromboembolic complications after Fontan procedures: Comparison of different therapeutic approaches. Ann Thorac Surg 2002; 74:556-562
51. Li JS, Yow E, Berezny KY, et al: Clinical outcomes of palliative surgery including a systemic-to-pulmonary artery shunt in infants with cyanotic congenital heart disease: Does aspirin make a difference? Circulation 2007; 116:293-297
52. Athale UH, Chan AK: Thrombosis in children with acute lymphoblastic leukemia. Part II. Pathogenesis of thrombosis in children with acute lymphoblastic leukemia: Effects of the disease and therapy. Thromb Res 2003; 111: 199-212
53. Korones DN, Buzzard CJ, Asselin BL, et al: Right atrial thrombi in children with cancer and indwelling catheters. J Pediatr 1996; 128:841-846
54. Deitcher SR, Gajjar A, Kun L, et al: Clinically evident venous thromboembolic events in children with brain tumors. J Pediatr 2004; 145:848-850
55. Tabori U, Beni-Adani L, Dvir R, et al: Risk of venous thromboembolism in pediatric patients with brain tumors. Pediatr Blood Cancer 2004; 43:633-636
56. Paz-Priel I, Long L, Helman LJ, et al: Throm-boembolic events in children and young adults with pediatric sarcoma. J Clin Oncol 2007; 25:1519-1524
57. Male C, Chait P, Ginsberg JS, et al: Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: Results of the PARKAA study. Prophylactic Anti-thrombin Replacement in Kids with ALL treated with Asparaginase. Thromb Haemost 2002; 87:593-598
58. Raffini L: Thrombophilia in children: who to test, how, when, and why? Hematology Am Soc Hematol Educ Program 2008:228-235
59. Manco-Johnson MJ, Grabowski EF, Hell-green M, et al: Laboratory testing for throm-bophilia in pediatric patients. On behalf of the Subcommittee for Perinatal and Pediat-ric Thrombosis of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis (ISTH). Thromb Haemost 2002; 88:155-156
60. Young G, Albisetti M, Bonduel M, et al: Impact of inherited thrombophilia on venous thromboembolism in children: A systematic review and meta-analysis of observational studies. Circulation 2008; 118:1373-1382
61. Nowak-Gottl U, Junker R, Kreuz W, et al: Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood 2001; 97:858-862 (Pubitemid 32154265)
62. Andrew M, Michelson AD, Bovill T, et al: The prevention and treatment of thromboem-bolic disease in children: A need for throm-bophilia programs. J Pediatr Hematol Oncol 1997; 19:7-22
63. Ravelli A, Martini A: Antiphospholipid syndrome in pediatrics. Rheum Dis Clin North Am 2007; 33:499-523
64. Schmugge M, Risch L, Huber AR, et al: He-parin-induced thrombocytopenia-associated thrombosis in pediatric intensive care patients. Pediatrics 2002; 109:E10
65. Risch L, Fischer JE, Herklotz R, et al: Hepa-rin-induced thrombocytopenia in paediatrics: Clinical characteristics, therapy and outcomes. Intensive Care Med 2004; 30: 1615-1624
66. Nowak-Gottl U, Bidlingmaier C, Krumpel A, et al: Pharmacokinetics, efficacy, and safety of LMWHs in venous thrombosis and stroke in neonates, infants and children. Br J Pharmacol 2008; 153:1120-1127
67. Choussat R, Montalescot G, Collet JP, et al: A unique, low dose of intravenous enoxaparin in elective percutaneous coronary intervention. J Am Coll Cardiol 2002; 40:1943-1950
68. Feng Y, Green B, Duffull SB, et al: Development of a dosage strategy in patients receiving enoxaparin by continuous intravenous infusion using modelling and simulation. Br J Clin Pharmacol 2006; 62:165-176
69. Massonnet-Castel S, Pelissier E, Bara L, et al: Partial reversal of low molecular weight hep-arin (PK 10169) anti-Xa activity by prota-mine sulfate: In vitro and in vivo study during cardiac surgery with extracorporeal circulation. Haemostasis 1986; 16:139-146
70. Streif W, Andrew M, Marzinotto V, et al: Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients. Blood 1999; 94:3007-3014
71. Custer J, Rau R: The Harriet Lane Handbook. 18th Edition. Philadelphia, Elsevier Mosby, 2009
72. Hursting MJ, Dubb J, Verme-Gibboney CN: Argatroban anticoagulation in pediatric patients: A literature analysis. J Pediatr Hema-tol Oncol 2006; 28:4-10
73. Deitcher SR, Topoulos AP, Bartholomew JR, et al: Lepirudin anticoagulation for heparin-induced thrombocytopenia. J Pediatr 2002; 140:264-266
74. Easley RB, Brady KM, Tobias JD: Hemato-logic Emergencies. In: Roger's Textbook of Pediatric Intensive Care. Fourth Edition. Nichols DG (Ed). Philadelphia, Lippincott Williams & Wilkins, 2008, pp 1725-1758
75. Wang M, Hays T, Balasa V, et al: Low-dose tissue plasminogen activator thrombolysis in children. J Pediatr Hematol Oncol 2003; 25: 379-386
76. Gupta AA, Leaker M, Andrew M, et al: Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intra-vascular thrombosis in children. J Pediatr 2001; 139:682-688
77. Cook A, Shackford S, Osler T, et al: Use of vena cava filters in pediatric trauma patients: Data from the National Trauma Data Bank. J Trauma 2005; 59:1114-1120
78. Caprini JA, Scurr JH, Hasty JH: Role of compression modalities in a prophylactic program for deep vein thrombosis. Semin Thromb Hemost 1988; 14(Suppl):77-87
79. Scurr JH, Coleridge-Smith PD, Hasty JH: Regimen for improved effectiveness of intermittent pneumatic compression in deep venous thrombosis prophylaxis. Surgery 1987; 102:816-820